Digma Medical
3 known investors
Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus. The device is designed for use in standard GI endoscopy suites and serves gastroenterology clinicians treating pre-cancerous and other GI pathologies.
Investors · 3
Founder mafia
2 people who came through Digma Medical went on to found or lead other companies.
In the news
Frequently asked questions
- What does Digma Medical do?
- Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus. The device is designed for use in standard GI endoscopy suites and serves gastroenterology clinicians treating pre-cancerous and other GI pathologies.
- Who are Digma Medical's investors?
- Digma Medical's investors include Accelmed Partners, Peregrine Ventures, Tal Ventures.